The ASX 200 is showing resilience, climbing over 37.9 points after the Australia Day long weekend, despite a tech downturn on Wall Street. Penny stocks, though considered a niche investment area today, continue to offer intriguing opportunities for growth at lower price points. These smaller or newer companies can present value and potential when supported by strong financials and solid fundamentals.
Name | Share Price | Market Cap | Financial Health Rating |
Embark Early Education (ASX:EVO) | A$0.76 | A$139.45M | ★★★★☆☆ |
LaserBond (ASX:LBL) | A$0.585 | A$68.57M | ★★★★★★ |
SHAPE Australia (ASX:SHA) | A$2.92 | A$242.1M | ★★★★★★ |
Austin Engineering (ASX:ANG) | A$0.50 | A$310.07M | ★★★★★☆ |
GTN (ASX:GTN) | A$0.55 | A$108.01M | ★★★★★★ |
Helloworld Travel (ASX:HLO) | A$1.945 | A$316.68M | ★★★★★★ |
IVE Group (ASX:IGL) | A$2.12 | A$328.36M | ★★★★☆☆ |
SKS Technologies Group (ASX:SKS) | A$1.59 | A$240.95M | ★★★★★★ |
Vita Life Sciences (ASX:VLS) | A$1.985 | A$110.44M | ★★★★★★ |
Centrepoint Alliance (ASX:CAF) | A$0.33 | A$65.63M | ★★★★★☆ |
Click here to see the full list of 1,026 stocks from our ASX Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Ballymore Resources Limited is an exploration and development company with a market capitalization of A$22.09 million.
Operations: Ballymore Resources Limited currently does not report any specific revenue segments.
Market Cap: A$22.09M
Ballymore Resources, with a market capitalization of A$22.09 million, is currently pre-revenue and unprofitable. The company has experienced high share price volatility over the past three months and has not demonstrated profit growth or improved net profit margins recently. Despite this, Ballymore's financial position shows strength with short-term assets of A$8.2 million exceeding both its short-term liabilities (A$775.6K) and long-term liabilities (A$7.8M). Additionally, it maintains more cash than total debt, providing a cash runway exceeding one year based on current free cash flow trends without significant shareholder dilution in the past year.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: FOS Capital Limited, with a market cap of A$19.10 million, operates in Australia and New Zealand through its subsidiaries to manufacture and distribute commercial luminaires, outdoor fittings, linear extruded lighting, and architectural lighting solutions.
Operations: The company generates revenue from its Electric Lighting & Other Fixtures segment, totaling A$24.53 million.
Market Cap: A$19.1M
FOS Capital, with a market cap of A$19.10 million, operates in the lighting sector and has demonstrated steady earnings growth of 8.7% per year over the last five years. The company's financial health appears stable, with short-term assets (A$12.5M) comfortably covering both short-term (A$7.7M) and long-term liabilities (A$4.2M). Despite experiencing a significant one-off loss impacting recent results, FOS maintains satisfactory debt levels and well-covered interest payments by EBIT at 5.8x coverage. Trading below estimated fair value suggests potential undervaluation; however, its low return on equity and unstable dividend history warrant caution for investors.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Midway Limited is involved in the production, processing, marketing, and export of woodfibre across Australia, China, Japan, and Southeast Asia with a market cap of A$108.30 million.
Operations: The company's revenue is primarily generated from its Woodfibre Processing segment, which accounts for A$284.55 million, complemented by its Plantation Management segment contributing A$10.88 million.
Market Cap: A$108.3M
Midway Limited, with a market cap of A$108.30 million, has recently become profitable despite a history of declining earnings. The company has announced a special dividend and is involved in an acquisition by River Capital Pty Ltd., which may result in all-cash consideration for shareholders if certain conditions aren't met. Midway's financial health appears robust, with short-term assets exceeding liabilities and debt well-covered by cash flow. However, the stock's high volatility and low return on equity might concern investors. Trading significantly below estimated fair value could indicate potential undervaluation amidst these dynamics.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:BMR ASX:FOS and ASX:MWY.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.